Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
DNA X, Inc. (SONM) had Stock-Based Compensation of $0.30M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$6.34M |
|
-- |
|
-- |
|
$3.62M |
|
$-3.62M |
|
$-0.31M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$-3.93M |
|
$6.34M |
|
$-3.93M |
|
$-3.62M |
|
$-3.58M |
|
1.27M |
|
1.27M |
|
$5.01 |
|
$5.01 |
|
| Balance Sheet Financials | |
$3.30M |
|
-- |
|
$1.53M |
|
$4.84M |
|
$4.32M |
|
-- |
|
$1.50M |
|
$5.82M |
|
$-0.98M |
|
$-0.98M |
|
$-0.98M |
|
1.27M |
|
| Cash Flow Statement Financials | |
$-3.47M |
|
$3.36M |
|
-- |
|
$1.30M |
|
$1.20M |
|
$-0.11M |
|
|
Stock-Based Compensation |
$0.30M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.76 |
|
-- |
|
-- |
|
-- |
|
-1.09 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-0.11M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
399.60% |
|
399.59% |
|
-81.19% |
|
399.59% |
|
$-0.78 |
|
$-0.09 |
|
$-2.74 |
|